HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Brown Advisory Inc.

Brown Advisory Inc. boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 53.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,630 shares of the company's stock after buying an additional 1,622 shares during the quarter. Brown Advisory Inc.'s holdings in HCA Healthcare were worth $1,600,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Farther Finance Advisors LLC boosted its stake in shares of HCA Healthcare by 26.9% during the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock worth $395,000 after buying an additional 242 shares during the period. Oppenheimer Asset Management Inc. boosted its stake in shares of HCA Healthcare by 2.5% during the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after buying an additional 105 shares during the period. GAMMA Investing LLC boosted its stake in shares of HCA Healthcare by 17.6% during the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock worth $1,704,000 after buying an additional 737 shares during the period. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth about $1,021,000. Finally, OLD National Bancorp IN boosted its stake in shares of HCA Healthcare by 5.2% during the first quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock worth $362,000 after buying an additional 52 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Trading Down 2.3%

Shares of HCA traded down $8.76 during mid-day trading on Tuesday, reaching $371.69. The company had a trading volume of 1,304,359 shares, compared to its average volume of 1,456,664. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The stock has a market cap of $89.42 billion, a price-to-earnings ratio of 16.53, a price-to-earnings-growth ratio of 1.31 and a beta of 1.47. The firm has a fifty day simple moving average of $375.75 and a 200-day simple moving average of $342.80. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.36 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.77%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on HCA shares. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their price target for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Robert W. Baird reaffirmed a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Finally, Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the company an "equal weight" rating in a report on Monday, June 9th. Seven research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $395.71.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.